Halliday, Glenda, Stephen R
Initiating GLP-1 therapy requires careful patient selection and thorough counseling about realistic expectations
Comorbidities such as cardiovascular disease, sleep apnea, or uncontrolled diabetes change priorities: reduce hypoglycemia risk, avoid volume depletion, and maintain glycemic targets that fit the procedures risk profile
Forms with generally good tolerability include: Magnesium glycinate : Chelated to the amino acid glycine, this form demonstrates good absorption and minimal laxative effect, making it potentially suitable for GLP-1 users already experiencing gastrointestinal symptoms
Vision changes in diabetic patients
To effectively manage this side effect, its essential to understand why it occurs and how it relates to the drugs mechanism of action